Stay updated on Bispecific Antibody MCLA-158 Clinical Trial

Sign up to get notified when there's something new on the Bispecific Antibody MCLA-158 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Bispecific Antibody MCLA-158 Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov page footer now identifies the site as revision v3.8.1 instead of v3.8.0.
    Difference
    0.0%
    Check dated 2026-11-18T02:22:32.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the Phase 1/2 MCLA-158 study is displayed with its recruitment information, participating locations, eligibility criteria, treatment arms, and outcome measures.
    Difference
    100%
    Check dated 2026-11-11T01:31:28.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site revision label changed from v3.7.2 to v3.8.0; the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T23:41:28.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    A site-wide NIH notice was added announcing a transition from “Artificial Intelligence” to “Super Intelligence,” and the footer revision advanced from v3.7.1 to v3.7.2. The page still displays a 403 Forbidden error.
    Difference
    1%
    Check dated 2026-10-20T23:38:23.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T00:17:03.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, replacing the usual content with an error message; the additions include a 403 header and a Home link, and the detailed study information is no longer accessible.
    Difference
    21%
    Check dated 2026-09-23T01:03:08.000Z thumbnail image

Stay in the know with updates to Bispecific Antibody MCLA-158 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Bispecific Antibody MCLA-158 Clinical Trial page.